2022
DOI: 10.1016/j.gim.2021.09.001
|View full text |Cite
|
Sign up to set email alerts
|

Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
63
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 64 publications
(63 citation statements)
references
References 41 publications
0
63
0
Order By: Relevance
“…While many computational tools are available for use in the clinical setting, they may generate conflicting or inaccurate predictions that can result in overlooking the true cause of a genetic disorder, especially when a synonymous variant is relatively common in controls, as seen with the c.327C>T, p.(Gly109=) variant. The synonymous variant in this study is predicted to introduce a cryptic splice donor site 2 bp upstream of the variant; however, the predicted score provided by an individual bioinformatics tool is still insufficient to satisfy the PP3 criteria (computational evidence of pathogenicity), even for the SpliceAI tool, which outperforms other tools in sensitivity and specificity (Bournazos et al, 2022; Jaganathan et al, 2019; Wai et al, 2020). Of note, SpliceAI predicts no impact of c.5331G>A, p.(Leu1777=) on splicing (Collin et al, 2008).…”
Section: Family‐individuala Hearing Loss Featuresb Genotypec Ethnicit...mentioning
confidence: 87%
See 1 more Smart Citation
“…While many computational tools are available for use in the clinical setting, they may generate conflicting or inaccurate predictions that can result in overlooking the true cause of a genetic disorder, especially when a synonymous variant is relatively common in controls, as seen with the c.327C>T, p.(Gly109=) variant. The synonymous variant in this study is predicted to introduce a cryptic splice donor site 2 bp upstream of the variant; however, the predicted score provided by an individual bioinformatics tool is still insufficient to satisfy the PP3 criteria (computational evidence of pathogenicity), even for the SpliceAI tool, which outperforms other tools in sensitivity and specificity (Bournazos et al, 2022; Jaganathan et al, 2019; Wai et al, 2020). Of note, SpliceAI predicts no impact of c.5331G>A, p.(Leu1777=) on splicing (Collin et al, 2008).…”
Section: Family‐individuala Hearing Loss Featuresb Genotypec Ethnicit...mentioning
confidence: 87%
“…The variant segregates with the disease in two affected relatives (PP1_supporting). Furthermore, in vitro minigene analysis suggests that this variant likely creates a cryptic donor site, leading to an out-of-frame transcript (PS3_supporting predicted to introduce a cryptic splice donor site 2 bp upstream of the variant; however, the predicted score provided by an individual bioinformatics tool is still insufficient to satisfy the PP3 criteria (computational evidence of pathogenicity), even for the SpliceAI tool, which outperforms other tools in sensitivity and specificity (Bournazos et al, 2022;Jaganathan et al, 2019;Wai et al, 2020).…”
mentioning
confidence: 99%
“…At least 50% of disease-causing variations are estimated to be splice site variants. Functional analyses of the spliced isoforms such as the minigene assay and RT-PCR can reclassify up to 75% of putative splicing variants [ 29 ]. The c.-1-2A>T and c.2247-2A>G variants belong to special types of PVS1 null variants.…”
Section: Discussionmentioning
confidence: 99%
“…LRS of messenger RNA has demonstrated the ability to detect many novel reading frames and isoforms previously unknown, in addition to allele-specific expression and variations in posttranscription RNA modifications. This knowledge will have utility in sequence variant interpretation in genetic testing (Bournazos et al, 2022). DNA methylation alterations have long been known as an underlying etiology in diseases such as imprinting defect conditions.…”
Section: Applications Of Lrs In Emerging Areas Of Molecular Diagnosticsmentioning
confidence: 99%